Literature DB >> 19496194

Prognosis of hepatocellular carcinoma accompanied by microscopic portal vein invasion.

Ken Shirabe1, Kiyoshi Kajiyama, Norifumi Harimoto, Hideaki Masumoto, Tatsuro Fukuya, Masafumi Ooya, Yoshihiko Maehara.   

Abstract

AIM: To investigate the prognostic factors in patients with hepatocellular carcinoma (HCC) accompanied by microscopic portal vein invasion (PVI).
METHODS: Of the 267 patients with HCC undergoing hepatic resection at Aso Iizuka Hospital, 71 had PVI. After excluding 16 patients with HCC that invaded the main trunk and the first and second branches of the portal vein, 55 patients with microscopic PVI were enrolled.
RESULTS: The patients with HCC accompanied by microscopic invasion were divided into two groups: solitary PVI (PVI-S: n = 44), and multiple PVIs (PVI-M: n = 11). The number of portal vein branches invaded by tumor thrombi was 5.4 +/- 3.8 (2-16) in patients with PVI-M. In cumulative survival, PVI-M was found to be a significantly poor prognostic factor (P = 0.0019); while PVI-M and non-anatomical resection were significantly poor prognostic factors in disease-free survival (P = 0.0213, and 0.0115, respectively). In patients with PVI-M, multiple intrahepatic recurrence was more common than in the patients with PVI-S (P = 0.0049). In patients with PVI-S, non-anatomical resection was a significantly poor prognostic factor in disease-free survival (P = 0.0370). Operative procedure was not a significant prognostic factor in patients with PVI-M.
CONCLUSION: The presence of PVI-M was a poor prognostic factor in patients with HCC, accompanied by microscopic PVI. Anatomical resection is recommended in these patients with HCC. Patients with HCC and PVI-M may also be good candidates for adjuvant chemotherapy.

Entities:  

Mesh:

Year:  2009        PMID: 19496194      PMCID: PMC2691495          DOI: 10.3748/wjg.15.2632

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  21 in total

1.  Portal vein evaluation with US: comparison to angiography combined with CT arterial portography.

Authors:  A M Bach; L E Hann; K T Brown; G I Getrajdman; S K Herman; Y Fong; L H Blumgart
Journal:  Radiology       Date:  1996-10       Impact factor: 11.105

2.  Tumor involvement in hepatic veins: comparison of MR imaging and US for preoperative assessment.

Authors:  L E Hann; L H Schwartz; D M Panicek; A M Bach; Y Fong; L H Blumgart
Journal:  Radiology       Date:  1998-03       Impact factor: 11.105

3.  Prediction of recurrence and prognosis in patients with hepatocellular carcinoma after resection by use of CLIP score.

Authors:  Wen-He Zhao; Zhi-Min Ma; Xing-Ren Zhou; Yi-Zheng Feng; Bao-Shan Fang
Journal:  World J Gastroenterol       Date:  2002-04       Impact factor: 5.742

4.  Survival and recurrence after liver transplantation versus liver resection for hepatocellular carcinoma: a retrospective analysis.

Authors:  G Otto; U Heuschen; W J Hofmann; G Krumm; U Hinz; C Herfarth
Journal:  Ann Surg       Date:  1998-03       Impact factor: 12.969

5.  Preoperative localization of focal liver lesions to specific liver segments: utility of CT during arterial portography.

Authors:  R C Nelson; J L Chezmar; P H Sugarbaker; D R Murray; M E Bernardino
Journal:  Radiology       Date:  1990-07       Impact factor: 11.105

6.  Factors correlated with portal venous invasion by hepatocellular carcinoma: univariate and multivariate analyses of 232 resected cases without preoperative treatments.

Authors:  E Adachi; T Maeda; K Kajiyama; N Kinukawa; T Matsumata; K Sugimachi; M Tsuneyoshi
Journal:  Cancer       Date:  1996-05-15       Impact factor: 6.860

7.  Factors linked to early recurrence of small hepatocellular carcinoma after hepatectomy: univariate and multivariate analyses.

Authors:  K Shirabe; T Kanematsu; T Matsumata; E Adachi; K Akazawa; K Sugimachi
Journal:  Hepatology       Date:  1991-11       Impact factor: 17.425

8.  Results of 280 liver resections for hepatocellular carcinoma.

Authors:  K Takenaka; N Kawahara; K Yamamoto; K Kajiyama; T Maeda; H Itasaka; K Shirabe; T Nishizaki; K Yanaga; K Sugimachi
Journal:  Arch Surg       Date:  1996-01

9.  Effect of a new adjuvant systemic interferon alpha, 5-fluorouracil and cisplatin on advanced hepatocellular carcinoma with macroscopic portal invasion.

Authors:  Satoru Imura; Tetsuya Ikemoto; Yuji Morine; Masahiko Fujii; Hidenori Miyake; Seiki Tashiro; Mitsuo Shimada
Journal:  Hepatogastroenterology       Date:  2008 Mar-Apr

10.  Reevaluation of prognostic factors for survival after liver resection in patients with hepatocellular carcinoma in a Japanese nationwide survey.

Authors:  Iwao Ikai; Shigeki Arii; Masamichi Kojiro; Takafumi Ichida; Masatoshi Makuuchi; Yutaka Matsuyama; Yasuni Nakanuma; Kiwamu Okita; Masao Omata; Kenichi Takayasu; Yoshio Yamaoka
Journal:  Cancer       Date:  2004-08-15       Impact factor: 6.860

View more
  18 in total

Review 1.  Advances in image-guided intratumoral drug delivery techniques.

Authors:  Luis Solorio; Ravi B Patel; Hanping Wu; Tianyi Krupka; Agata A Exner
Journal:  Ther Deliv       Date:  2010-08

2.  Clinicopathological characteristics of 20 cases of hepatocellular carcinoma with bile duct tumor thrombi.

Authors:  Xian-huan Yu; Lei-bo Xu; Chao Liu; Rui Zhang; Jie Wang
Journal:  Dig Dis Sci       Date:  2010-05-01       Impact factor: 3.199

3.  Risk factors and therapeutic results of early local recurrence after transcatheter arterial chemoembolization.

Authors:  Woo Sun Rou; Byung Seok Lee; Hee Seok Moon; Eaum Seok Lee; Seok Hyun Kim; Heon Young Lee
Journal:  World J Gastroenterol       Date:  2014-06-14       Impact factor: 5.742

4.  Clinicopathological Characteristics of Hepatocellular Carcinoma with Microscopic Portal Venous Invasion and the Role of Anatomical Liver Resection in These Cases.

Authors:  Shingo Shimada; Toshiya Kamiyama; Hideki Yokoo; Tatsuya Orimo; Kenji Wakayama; Takahiro Einama; Tatsuhiko Kakisaka; Hirofumi Kamachi; Akinobu Taketomi
Journal:  World J Surg       Date:  2017-08       Impact factor: 3.352

5.  Analysis of DNA methylation in plasma for monitoring hepatocarcinogenesis.

Authors:  Wenqing Huang; Tong Li; Wenli Yang; Xinjuan Chai; Kefei Chen; Ling Wei; Shuwang Duan; Bo Li; Yang Qin
Journal:  Genet Test Mol Biomarkers       Date:  2015-04-29

6.  The Value of the C-Reactive Protein-to-Albumin Ratio is Useful for Predicting Survival of Patients with Child-Pugh Class A Undergoing Liver Resection for Hepatocellular Carcinoma.

Authors:  Takayuki Shimizu; Mitsuru Ishizuka; Takashi Suzuki; Genki Tanaka; Takayuki Shiraki; Yuhki Sakuraoka; Takatsugu Matsumoto; Masato Kato; Taku Aoki; Keiichi Kubota
Journal:  World J Surg       Date:  2018-07       Impact factor: 3.352

Review 7.  Reappraisal of evidence of microscopic portal vein involvement by hepatocellular carcinoma cells with stratification of tumor size.

Authors:  Yuesi Zhong; Meihai Deng; Ruiyun Xu
Journal:  World J Surg       Date:  2015-05       Impact factor: 3.352

8.  Outcome of hepatectomy for hepatocellular carcinoma in patients with renal dysfunction.

Authors:  Takeo Toshima; Ken Shirabe; Shohei Yoshiya; Jun Muto; Toru Ikegami; Tomoharu Yoshizumi; Yoshihiko Maehara
Journal:  HPB (Oxford)       Date:  2012-05       Impact factor: 3.647

9.  Correlation of KAI1, CD133 and vasculogenic mimicry with the prediction of metastasis and prognosis in hepatocellular carcinoma.

Authors:  Jing Xu; Yu Zhang; Yichao Wang; Xiaoying Tao; Lili Cheng; Shiwu Wu; Yisheng Tao
Journal:  Int J Clin Exp Pathol       Date:  2018-07-01

10.  The Asia Pacific Consensus Statement on Laparoscopic Liver Resection for Hepatocellular Carcinoma: A Report from the 7th Asia-Pacific Primary Liver Cancer Expert Meeting Held in Hong Kong.

Authors:  Tan To Cheung; Ho-Seong Han; Wong Hoi She; Kuo-Hsin Chen; Pierce K H Chow; Boon Koon Yoong; Kit Fai Lee; Shoji Kubo; Chung Ngai Tang; Go Wakabayashi
Journal:  Liver Cancer       Date:  2017-12-09       Impact factor: 11.740

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.